Administration May Target Medicare Part B and D Plans in Efforts to Lower Drug Costs

Drug Industry Daily
HHS Secretary Alex Azar offered more details on Monday of a plan that could expand Medicare’s ability to negotiate prices, implicitly responding to claims that the administration’s new drug pricing blueprint is too easy on drugmakers.

To View This Article:


Subscribe To Drug Industry Daily